EPH3 Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.534
https://www.valueinhealthjournal.com/article/S1098-3015(25)00659-X/fulltext
Title :
EPH3 Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)00659-X&doi=10.1016/j.jval.2025.04.534
First page :
Section Title :
Open access? :
No
Section Order :
10311